279 related articles for article (PubMed ID: 34710530)
1. Delivery of synthetic mRNAs for tissue regeneration.
Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
[TBL] [Abstract][Full Text] [Related]
2. Synthetic modified messenger RNA for therapeutic applications.
Gao M; Zhang Q; Feng XH; Liu J
Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale platforms for messenger RNA delivery.
Li B; Zhang X; Dong Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled mRNA vaccines.
Kim J; Eygeris Y; Gupta M; Sahay G
Adv Drug Deliv Rev; 2021 Mar; 170():83-112. PubMed ID: 33400957
[TBL] [Abstract][Full Text] [Related]
5. Advances in mRNA non-viral delivery approaches.
Ibba ML; Ciccone G; Esposito CL; Catuogno S; Giangrande PH
Adv Drug Deliv Rev; 2021 Oct; 177():113930. PubMed ID: 34403751
[TBL] [Abstract][Full Text] [Related]
6. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
Forenzo C; Larsen J
Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
[TBL] [Abstract][Full Text] [Related]
7. Repairing the heart: State-of the art delivery strategies for biological therapeutics.
Yang Q; Fang J; Lei Z; Sluijter JPG; Schiffelers R
Adv Drug Deliv Rev; 2020; 160():1-18. PubMed ID: 33039498
[TBL] [Abstract][Full Text] [Related]
8. mRNA delivery technologies: Toward clinical translation.
Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and Challenges for mRNA Delivery Nanoplatforms.
Zhang Y; Hu Y; Tian H; Chen X
J Phys Chem Lett; 2022 Feb; 13(5):1314-1322. PubMed ID: 35107010
[TBL] [Abstract][Full Text] [Related]
10. Synthetic mRNA - emerging new class of drug for tissue regeneration.
Balmayor ER
Curr Opin Biotechnol; 2022 Apr; 74():8-14. PubMed ID: 34749063
[TBL] [Abstract][Full Text] [Related]
11. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.
Rybakova Y; Kowalski PS; Huang Y; Gonzalez JT; Heartlein MW; DeRosa F; Delcassian D; Anderson DG
Mol Ther; 2019 Aug; 27(8):1415-1423. PubMed ID: 31160223
[TBL] [Abstract][Full Text] [Related]
12. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.
Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R
BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652
[TBL] [Abstract][Full Text] [Related]
13. The Impact of mRNA Technology in Regenerative Therapy: Lessons for Oral Tissue Regeneration.
Wisitrasameewong W; Champaiboon C; Surisaeng T; Sa-Ard-Iam N; Freire M; Pardi N; Pichyangkul S; Mahanonda R
J Dent Res; 2022 Aug; 101(9):1015-1024. PubMed ID: 35319289
[TBL] [Abstract][Full Text] [Related]
14. Materials for non-viral intracellular delivery of messenger RNA therapeutics.
Kauffman KJ; Webber MJ; Anderson DG
J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856
[TBL] [Abstract][Full Text] [Related]
15. mRNA-based therapeutics--developing a new class of drugs.
Sahin U; Karikó K; Türeci Ö
Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
[TBL] [Abstract][Full Text] [Related]
16. mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.
Chabanovska O; Galow AM; David R; Lemcke H
Adv Drug Deliv Rev; 2021 Dec; 179():114002. PubMed ID: 34653534
[TBL] [Abstract][Full Text] [Related]
17. Developing mRNA for Therapy.
Karikó K
Keio J Med; 2022; 71(1):31. PubMed ID: 35342149
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.
Sultana N; Sharkar MTK; Hadas Y; Chepurko E; Zangi L
Methods Mol Biol; 2021; 2158():281-294. PubMed ID: 32857381
[TBL] [Abstract][Full Text] [Related]
19. The nano delivery systems and applications of mRNA.
Li M; Li Y; Li S; Jia L; Wang H; Li M; Deng J; Zhu A; Ma L; Li W; Yu P; Zhu T
Eur J Med Chem; 2022 Jan; 227():113910. PubMed ID: 34689071
[TBL] [Abstract][Full Text] [Related]
20. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
Chatzikleanthous D; O'Hagan DT; Adamo R
Mol Pharm; 2021 Aug; 18(8):2867-2888. PubMed ID: 34264684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
